Mesoblast Ltd - Company Profile
Powered by 
All the sales intelligence you need on Mesoblast Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Mesoblast Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Mesoblast Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Mesoblast Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2022261504A1 | Application | Method for treating acute respiratory distress syndrome (ARDS) in specific patients using mesenchymal lineage precursor or stem cells | A61K31/573; A61K35/28; A61P31/12; A61P31/14 | November 30, 2023 |
| WO2023228153A1 | Application | High flow filter and method of use | C12M23/14; C12M23/34; C12M33/14; C12M47/02; A61M1/0281; A61M1/3636; B01D29/05; B01D29/56 | November 30, 2023 |
| AU2022260822A1 | Application | Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells | A61K31/573; A61K35/28; A61P31/12; A61P31/14 | November 30, 2023 |
| EP4281088A1 | Application | Opioidschonende zusammensetzungen und verfahren zur verwendung davon | A61K35/28; A61K47/36; A61P29/02 | November 29, 2023 |
| US11821004B2 | Grant | Mesenchymal stem cells expressing tnf-a receptors | C12N2501/25; C12N5/0662; C12N5/0663; A61K2035/122; A61K35/28; G01N2333/525 | November 21, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer